Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C173043> ?p ?o ?g. }
Showing items 1 to 24 of
24
with 100 items per page.
- NCIT_C173043 IAO_0000115 "The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with ulixertinib in patients with tumors that have BRAF fusions or BRAF gene mutations, excluding those with BRAF V600E or V600K substitution mutations and central nervous system primary malignancy." @default.
- NCIT_C173043 NCIT_NHC0 "C173043" @default.
- NCIT_C173043 NCIT_P106 "Intellectual Product" @default.
- NCIT_C173043 NCIT_P108 "MATCH Arm EAY131-Z1L" @default.
- NCIT_C173043 NCIT_P208 "CL1406813" @default.
- NCIT_C173043 NCIT_P322 "CTDC" @default.
- NCIT_C173043 normalizedInformationContent "100" @default.
- NCIT_C173043 referenceCount "1" @default.
- NCIT_C173043 hasExactSynonym "EAY131-Z1L" @default.
- NCIT_C173043 hasExactSynonym "MATCH Arm EAY131-Z1L" @default.
- NCIT_C173043 hasExactSynonym "Z1L" @default.
- NCIT_C173043 inSubset NCIT_C173073 @default.
- NCIT_C173043 type Class @default.
- NCIT_C173043 isDefinedBy ncit.owl @default.
- NCIT_C173043 label "MATCH Arm EAY131-Z1L" @default.
- NCIT_C173043 subClassOf NCIT_C171181 @default.
- NCIT_C173043 subClassOf NCIT_C172991 @default.
- NCIT_C173043 subClassOf NCIT_C173043 @default.
- NCIT_C173043 subClassOf NCIT_C19498 @default.
- NCIT_C173043 subClassOf NCIT_C20181 @default.
- NCIT_C173043 subClassOf NCIT_C25198 @default.
- NCIT_C173043 subClassOf NCIT_C25364 @default.
- NCIT_C173043 subClassOf NCIT_C70663 @default.
- NCIT_C173043 subClassOf NCIT_C97331 @default.